Teacher Retirement System of Texas Has $75.92 Million Holdings in Humana Inc (HUM)

Teacher Retirement System of Texas grew its position in Humana Inc (NYSE:HUM) by 7.2% during the 2nd quarter, Holdings Channel reports. The firm owned 255,095 shares of the insurance provider’s stock after purchasing an additional 17,104 shares during the period. Teacher Retirement System of Texas’ holdings in Humana were worth $75,924,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Boston Advisors LLC lifted its stake in shares of Humana by 27.0% during the second quarter. Boston Advisors LLC now owns 138,043 shares of the insurance provider’s stock worth $41,086,000 after buying an additional 29,367 shares during the period. Glenview Trust Co lifted its stake in shares of Humana by 7.4% during the first quarter. Glenview Trust Co now owns 35,695 shares of the insurance provider’s stock worth $9,596,000 after buying an additional 2,456 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in shares of Humana by 80.1% during the first quarter. Massachusetts Financial Services Co. MA now owns 741,942 shares of the insurance provider’s stock worth $199,454,000 after buying an additional 329,956 shares during the period. Amalgamated Bank lifted its stake in shares of Humana by 6.7% during the second quarter. Amalgamated Bank now owns 21,322 shares of the insurance provider’s stock worth $6,346,000 after buying an additional 1,334 shares during the period. Finally, World Asset Management Inc lifted its stake in shares of Humana by 2.9% during the second quarter. World Asset Management Inc now owns 10,239 shares of the insurance provider’s stock worth $3,047,000 after buying an additional 284 shares during the period. 93.78% of the stock is currently owned by institutional investors and hedge funds.

HUM has been the subject of several research reports. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $326.00 price objective for the company in a research note on Monday, May 21st. Argus lifted their price objective on shares of Humana from $270.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, April 16th. Citigroup reiterated a “buy” rating and set a $340.00 price objective (up from $280.00) on shares of Humana in a research note on Friday, June 1st. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Wednesday, July 4th. Finally, Jefferies Financial Group lifted their price objective on shares of Humana from $356.00 to $372.00 and gave the stock a “buy” rating in a research note on Thursday, August 2nd. Seven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Humana has a consensus rating of “Buy” and a consensus price target of $318.17.

In related news, SVP Cynthia H. Zipperle sold 4,886 shares of the business’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $321.89, for a total transaction of $1,572,754.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Roy A. Beveridge sold 14,306 shares of the business’s stock in a transaction on Monday, August 6th. The shares were sold at an average price of $324.25, for a total transaction of $4,638,720.50. Following the transaction, the insider now owns 15,274 shares of the company’s stock, valued at $4,952,594.50. The disclosure for this sale can be found here. Insiders have sold 104,976 shares of company stock valued at $32,165,337 over the last 90 days. 0.60% of the stock is currently owned by insiders.

NYSE HUM opened at $325.04 on Friday. The firm has a market cap of $44.60 billion, a P/E ratio of 25.35, a price-to-earnings-growth ratio of 1.61 and a beta of 0.93. Humana Inc has a 1 year low of $231.90 and a 1 year high of $327.50. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.43 and a quick ratio of 1.43.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.79 by $0.17. The company had revenue of $14.26 billion during the quarter, compared to the consensus estimate of $14.16 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the previous year, the firm posted $3.49 earnings per share. equities analysts predict that Humana Inc will post 14.18 EPS for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Read More: Earnings Per Share

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply